Study at a glance
What was studied?
Researchers studied vitamin D exposure before birth and later development. Human trials measured growth, bone scans and fractures. Rat and mouse experiments examined changes in pancreatic cells and developing blood and immune cells.
What did the studies find?
Changing supplements raised blood measurements in human trials, but did not consistently improve later outcomes. Some childhood bone scans were favourable; other growth and bone outcomes showed no clear difference. Animal experiments found changes in particular tissues or cell populations.
What does this mean?
A blood change, an animal cell finding and a benefit to a child are different results. An effect measured at one age does not prove that it lasts throughout life.
What are the limits?
We could not obtain the full 2026 MAVIDOS report on small-scale bone structure. Its abstract reports no detected group difference, but we could not fully assess its methods or results. Other limits include selected follow-up groups and differences between animal experiments and people.
Read the full article below ↓Vitamin D studies before birth do not all ask the same question. Some examine cells or organs in animals. Others measure a child’s growth, bones or later health. This summary compares five independent study programmes. They show why a change during development does not automatically mean a lasting health benefit, and why a blood result cannot replace a measured childhood outcome. For the detailed evidence review, read Vitamin D in Early Development: Programming and Later Outcomes: Full Evidence Review.
What was studied?
Researchers studied maternal vitamin D exposure, later outcomes in children, and developmental changes in rats and mice. Some studies randomly assigned pregnant women to different supplements. Other experiments changed maternal diets or transferred cells between animals. These are different kinds of evidence and cannot be interpreted in the same way.
The main blood measure was often 25-hydroxyvitamin D, also called 25(OH)D. It is a substance used to assess vitamin D status. It differs from vitamin D3 in a supplement and from the active vitamin D hormone. A higher blood result does not directly show that a developing organ works better. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D explains the blood markers, and Vitamin D Activation describes how vitamin D changes between forms.
A supporting study examined human placentas collected at the end of pregnancy. It showed that the placenta can take up and handle vitamin D substances. This helps explain exposure, but it does not show that a supplement improves a child’s later health. Placental tissue studied outside the body also cannot represent every stage of pregnancy.
What happened in the human trials?
The MDIG trial included 1,300 pregnant women in Bangladesh. The assigned supplements changed vitamin D blood measurements, but the researchers did not detect an improvement in the main outcome of infant length relative to age at one year. All groups also received calcium and other care. The finding concerns that trial’s conditions; it does not mean vitamin D is unnecessary for development. A later published correction did not change the overall conclusion.
The UK MAVIDOS trial compared vitamin D3 with placebo during pregnancy. Its main newborn bone measurement did not clearly improve overall. A later follow-up at about six to seven years found some favourable bone-scan results. However, the follow-up was exploratory and included a selected group of children. Several bone measurements were examined, and results were not identical across all measurements.
A 2026 MAVIDOS report examined the small-scale structure of bone. Its abstract reports no detected difference between the groups. We could not obtain the complete paper and its important supplementary material. We therefore could not fully assess the methods or detailed results. This gap matters when comparing that report with the earlier favourable scans. The abstract should be acknowledged, but it cannot stand in for a complete assessment.
The Danish COPSAC trial followed offspring to age 13. It did not establish an improvement in the bone measurements studied or a reduction in fractures. The estimates were uncertain. Children were not followed into adulthood in that report, so it cannot answer questions about lifelong protection.
These trials do not give one simple result for every age or outcome. A favourable scan at one age is not proof of fewer fractures later. Bone Mineralisation, Turnover and Fractures Measure Different Outcomes explains these differences in bone measurements. A result with no clear difference is also not proof that the two treatments have exactly the same effect in every setting.
What did animal experiments add?
In a rat study, maternal vitamin D deficiency covered pregnancy and breastfeeding. Male offspring later had lower selected insulin measurements and less mass of pancreatic beta cells, which produce insulin. The pancreas contains cells that produce insulin. The study did not show the same effect in every test or in both sexes. It also did not establish the proposed change in DNA regulation as the explanation. These results do not show that supplementation prevents diabetes in children.
A mouse experiment examined developing blood and immune-cell populations. Problems handling glucose and responding to insulin persisted after cells were transferred into adult mice receiving vitamin D. This supports further research into how early exposure may affect cells. But transplantation is an artificial setting, and the transferred samples contained different mixtures of cells. A small human cord-blood component was not a follow-up of children’s health.
What does this mean?
Early exposure can affect particular developmental processes in experiments. Human trials also show that supplements can change blood measurements. Neither fact guarantees a lasting health benefit. The species, timing, measured outcome and length of follow-up all matter.
This review has limits. The full 2026 MAVIDOS bone-structure report was unavailable, and some other detailed supplementary analyses were not inspected. The review therefore avoids claims that depend on those missing details. It also does not cover every developing organ. The missing information is a reason to limit conclusions, not to hide reported contrary findings.
For current UK advice, see NHS Pregnancy vitamins and supplements. These studies do not establish one personal dose or blood target.
Sources
Related reading
Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes
Environmental factors may alter the fetal genome to cause metabolic diseases.
Original paper ↗Read more →Maternal Vitamin D Deficiency Impairs the Development of β Cells in Offspring Rats in a Sex-Dependent Manner
Recent studies have shown that maternal vitamin D deficiency (VDD) causes long-term metabolic changes in offspring.
Original paper ↗Read more →Vitamin D in Early Development: Programming and Later Outcomes: Full Evidence Review
Prenatal trials and animal experiments on vitamin D programming and later offspring outcomes, with differences between ages, endpoints and missing sources.
Read more →Age-specific effects of weight-based body size on fracture risk in later life: a lifecourse Mendelian randomisation study
Musculoskeletal conditions, including fractures, can have severe and long-lasting consequences.
Original paper ↗Read more →Development and validation of a nomogram for predicting new vertebral compression fractures after percutaneous kyphoplasty in postmenopausal patients
This study aimed to develop and validate a visual nomogram model capable of accurately predicting NVCF occurrence post-PKP to optimize treatment strategies and minimize occurrence.
Original paper ↗Read more →Development of a laboratory-based frailty index for risk prediction in elderly trauma patients with hip fractures
This study aimed to develop a laboratory-based frailty index (FI-Lab) to predict 12-month mortality risk in elderly patients following a hip fracture (HF).
Original paper ↗Read more →Development of a Multidisciplinary Care Pathway for Fracture Prevention in Men with Prostate Cancer at Initiation of Androgen Deprivation Therapy
The ongoing implementation and evaluation aim to enhance fracture preventive care for men with prostate cancer starting ADT.
Original paper ↗Read more →Development of a Prediction Model for Stress Fracture During an Intensive Physical Training Program: The Royal Marines Commandos
Stress fractures (SFs) are one of the more severe overuse injuries in military training, and therefore, knowledge of potential risk factors is needed to assist in developing mitigating strategies.
Original paper ↗Read more →Prevalence and Determinants of Impaired Bone Mineral Density and Fractures in the First National Dutch Wilms Tumor Survivor Cohort, a National DCCSS‐LATER Study
We aimed to assess the prevalence and determinants of impaired bone mineral density (BMD) and fractures in a national cohort of Dutch WT survivors.
Original paper ↗Read more →The Application of Machine Learning in Predicting Mortality Risk in Patients With Severe Femoral Neck Fractures: Prediction Model Development Study
Femoral neck fracture (FNF) accounts for approximately 3.58% of all fractures in the entire body, exhibiting an increasing trend each year.
Original paper ↗Read more →Bone Mineralisation, Turnover and Fractures Measure Different Outcomes
Understand what bone mineralisation, resorption markers and fractures measure, using vitamin D experiments and the VITAL trial as distinct examples.
Read more →A Case Study of Discordant Overlapping Meta-Analyses: Vitamin D Supplements and Fracture
To explore why discordant results arise, we examined a common topic for overlapping meta-analyses: vitamin D supplements and fracture.
Original paper ↗Read more →Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly
We aimed to investigate the role of cholecalciferol (D3) supplementation in the prevention of incident VFs (i-VFs) in acromegaly.
Original paper ↗Read more →Impact of hypogonadism on bone mineral density and vertebral fractures in HIV-infected men
We evaluated the prevalence of osteoporosis and vertebral fractures (VFs) in HIV-infected men, and assessed their relationship with gonadal function.
Original paper ↗Read more →Impact of multidimensional assessment on anti-fracture treatment decisions in patients with fragility hip fractures within a Fracture Liaison Service
This study aimed to identify the primary factors influencing anti-fracture therapy decisions in older patients with fragility fractures, using a multidimensional geriatric assessment approach integrated into our FLS program.
Original paper ↗Read more →Implementation of fracture risk assessment in men with prostate cancer requiring long-term androgen deprivation therapy: a systematic scoping review using the i-PARIHS implementation framework
Androgen deprivation therapy (ADT) is a mainstay of treatment for prostate cancer (PCa) and is associated with increased risks of osteoporosis and fragility fractures.
Original paper ↗Read more →Perioperative risk factors in patients with a femoral neck fracture: influence of 25-hydroxyvitamin D and C-reactive protein on postoperative medical complications and 1-year mortality
This study examined the association of 25-hydroxyvitamin D (25(OH)D) and C-reactive protein (CRP) with postoperative medical complications and one year mortality of elderly patients sustaining a low-energy cervical hip fracture scheduled for surgery.
Original paper ↗Read more →Prediction of subsequent fragility fractures: application of machine learning
In this study, we aim to evaluate the predictive power of different ML algorithms in this area and identify key features associated with the risk of subsequent fragility fractures in osteoporotic patients.
Original paper ↗Read more →Prevention of Fractures in Older People with Calcium and Vitamin D
The greatest cause of fracture in older people is osteoporosis which contributes to increased morbidity and mortality in older people.
Original paper ↗Read more →Surgical management and outcomes following atypical subtrochanteric femoral fractures − results from a matched-pair analysis of the registry for geriatric trauma of the German Trauma Society
Data from a large international geriatric trauma registry were analysed to examine the outcome of patients with ASFs compared to patients with typical osteoporotic subtrochanteric fractures (TSFs).
Original paper ↗Read more →Vitamin D and Postoperative Recovery in Elderly Ribeirinhos: Riverside Amazon Communities with Femur Fractures
This study investigated whether pre-existing vitamin D supplementation influences postoperative outcomes in elderly Ribeirinhos following femur fracture surgery, while examining metabolic parameters and documenting chronic disease prevalence.
Original paper ↗Read more →Original sources
Pregnancy vitamins and supplements
For current UK advice, see NHS Pregnancy vitamins and supplements.
Publication details
For current UK advice, see NHS Pregnancy vitamins and supplements. These studies do not establish one personal dose or blood target.
Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit
Published in Ashley et al. eLife (2022).
Publication details
Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit. Ashley et al. eLife. 2022;11:e71094. DOI:10.7554/eLife.71094. Principal assessed for bounded physiological context; no raw omics reanalysis.
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth
Published in Roth et al. New England Journal of Medicine (2018).
Publication details
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. Roth et al. New England Journal of Medicine. 2018;379:535 to 546. DOI:10.1056/NEJMoa1800927. Principal assessed; interpretation incorporates the 2021 correction, DOI:10.1056/NEJMx210014. Archived numerical details may predate the correction.
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial
Published in Cooper et al. Lancet Diabetes & Endocrinology (2016).
Publication details
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. Cooper et al. Lancet Diabetes & Endocrinology. 2016;4:393 to 402. DOI:10.1016/S2213-8587(16)00044-9. Principal and relevant supplementary material assessed.
Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial
Published in Moon et al. American Journal of Clinical Nutrition (2024).
Publication details
Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial. Moon et al. American Journal of Clinical Nutrition. 2024;120:1134 to 1142. DOI:10.1016/j.ajcnut.2024.09.014. Principal and eight supplementary tables assessed; same MAVIDOS trial.
Vitamin D supplementation during pregnancy and offspring bone microarchitecture: A post hoc analysis of the MAVIDOS randomised controlled trial
Published in Maden et al. Bone (2026).
Publication details
Vitamin D supplementation during pregnancy and offspring bone microarchitecture: A post hoc analysis of the MAVIDOS randomised controlled trial. Maden et al. Bone. 2026;207:117843. DOI:10.1016/j.bone.2026.117843. ABSTRACT ONLY: full principal and material supplements unavailable; not counted as fully assessed evidence.
Prenatal high-dose vitamin D supplementation and offspring bone mineral content and density at age 13 years: a secondary analysis of a randomised clinical trial
Published in Brustad et al. Lancet Regional Health: Europe (2026).
Publication details
Prenatal high-dose vitamin D supplementation and offspring bone mineral content and density at age 13 years: a secondary analysis of a randomised clinical trial. Brustad et al. Lancet Regional Health: Europe. 2026;71:101870. DOI:10.1016/j.lanepe.2026.101870. Principal, material supplementary tables and relevant protocol history assessed; earlier COPSAC reports are the same trial.
Maternal Vitamin D Deficiency Impairs the Development of β Cells in Offspring Rats in a Sex-Dependent Manner
Recent studies have shown that maternal vitamin D deficiency (VDD) causes long-term metabolic changes in offspring.
Publication details
Maternal Vitamin D Deficiency Impairs the Development of β Cells in Offspring Rats in a Sex-Dependent Manner. Schavinski et al. International Journal of Molecular Sciences. 2024;25:4136. DOI:10.3390/ijms25084136. Principal, tables, figure descriptions and diet appendix assessed.
Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes
Published in Oh et al. Nature Communications (2023).
Publication details
Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh et al. Nature Communications. 2023;14:3278. DOI:10.1038/s41467-023-38849-z. Principal and material supplementary evidence assessed; no raw-data reanalysis. Experimental and human cord-cell components form one programme.